Great Point Partners Invests $19.68 Million in RAPT Therapeutics Amid 502.5% Stock Surge and Acquisition Offer

miércoles, 25 de febrero de 2026, 3:28 pm ET1 min de lectura
RAPT--

Great Point Partners acquired 581,187 shares of RAPT Therapeutics in Q4, increasing the quarter-end position value by $19.68 million. RAPT Therapeutics now accounts for 6.38% of the fund's AUM. The stock has surged 502.5% in the past year and a buyout offer has emerged.

Great Point Partners Invests $19.68 Million in RAPT Therapeutics Amid 502.5% Stock Surge and Acquisition Offer

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios